Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites.

Bibliographic Details
Title: Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites.
Authors: Alshuwaykh, Omar1 (AUTHOR), Cheung, Amanda1 (AUTHOR), Goel, Aparna1 (AUTHOR), Kwong, Allison1 (AUTHOR), Dhanasekaran, Renumathy1 (AUTHOR), Ghaziani, T. Tara1 (AUTHOR), Ahmed, Aijaz1 (AUTHOR), Daugherty, Tami1 (AUTHOR), Dronamraju, Deepti1 (AUTHOR), Kumari, Radhika1 (AUTHOR), Nguyen, Mindie1 (AUTHOR), Kim, W. Ray1 (AUTHOR), Kwo, Paul Yien1,2 (AUTHOR) pkwo@stanford.edu
Source: BMC Gastroenterology. 9/5/2022, Vol. 22 Issue 1, p1-9. 9p.
Subject Terms: *ASCITES, *LIVER metastasis, *TREATMENT effectiveness, *PORTAL hypertension, *PANCREATIC cancer
Abstract: Background: Malignancy-related ascites accounts for approximately 10% of causes of ascites. Our AIM was to characterize the ascites fluid and correlate clinical outcomes in those with extrahepatic malignancy and ascites.Methods: 241 subjects with extrahepatic solid tumors and ascites were reviewed from 1/1/2000 to 12/31/2019, 119 without liver metastasis and 122 with liver metastasis.Results: Ascites fluid consistent with peritoneal carcinomatosis (PC) was most common, 150/241 (62%), followed by fluid reflecting the presence of portal hypertension (PH), 69/241 (29%). 22/241 (9%) had low SAAG and low ascites fluid total protein, with evidence of PC on cytology and or imaging in 20/22. Lung cancer was the most common malignancy in subjects with ascites due to PC at 36/150 (24%), pancreatic cancer was the most common in subjects with ascites with features of PH at 16/69 (23%). Chemotherapy or immunotherapy alone was the most common management approach. Significantly higher 5-year, 3-year and 1-year mortality rate were noted in subjects with evidence of PC on cytology/imaging versus subjects with no evidence of PC, and in subjects with liver metastasis compared to subjects without liver metastasis. Subjects with pancreatic cancer and evidence of PC on cytology/imaging had higher 1 and 5-year mortality rates compared to subjects without PC.Conclusions: Ascites in solid tumor malignancy is most commonly due to PC. We also observed ascites fluid with characteristics of PH in 29% of subjects. Higher mortality rates in subjects with peritoneal carcinomatosis and liver metastasis were noted. These findings may help inform prognosis and treatment strategies. [ABSTRACT FROM AUTHOR]
Copyright of BMC Gastroenterology is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:a9h&genre=article&issn=1471230X&ISBN=&volume=22&issue=1&date=20220905&spage=1&pages=1-9&title=BMC Gastroenterology&atitle=Clinical%20characteristics%20and%20outcomes%20in%20those%20with%20primary%20extrahepatic%20malignancy%20and%20malignant%20ascites.&aulast=Alshuwaykh%2C%20Omar&id=DOI:10.1186/s12876-022-02487-4
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
Header DbId: a9h
DbLabel: Academic Search Complete
An: 158904581
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Alshuwaykh%2C+Omar%22">Alshuwaykh, Omar</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cheung%2C+Amanda%22">Cheung, Amanda</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Goel%2C+Aparna%22">Goel, Aparna</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kwong%2C+Allison%22">Kwong, Allison</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dhanasekaran%2C+Renumathy%22">Dhanasekaran, Renumathy</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ghaziani%2C+T%2E+Tara%22">Ghaziani, T. Tara</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ahmed%2C+Aijaz%22">Ahmed, Aijaz</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Daugherty%2C+Tami%22">Daugherty, Tami</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dronamraju%2C+Deepti%22">Dronamraju, Deepti</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kumari%2C+Radhika%22">Kumari, Radhika</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nguyen%2C+Mindie%22">Nguyen, Mindie</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kim%2C+W%2E+Ray%22">Kim, W. Ray</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kwo%2C+Paul+Yien%22">Kwo, Paul Yien</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> pkwo@stanford.edu</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22BMC+Gastroenterology%22">BMC Gastroenterology</searchLink>. 9/5/2022, Vol. 22 Issue 1, p1-9. 9p.
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: *<searchLink fieldCode="DE" term="%22ASCITES%22">ASCITES</searchLink><br />*<searchLink fieldCode="DE" term="%22LIVER+metastasis%22">LIVER metastasis</searchLink><br />*<searchLink fieldCode="DE" term="%22TREATMENT+effectiveness%22">TREATMENT effectiveness</searchLink><br />*<searchLink fieldCode="DE" term="%22PORTAL+hypertension%22">PORTAL hypertension</searchLink><br />*<searchLink fieldCode="DE" term="%22PANCREATIC+cancer%22">PANCREATIC cancer</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: <bold>Background: </bold>Malignancy-related ascites accounts for approximately 10% of causes of ascites. Our AIM was to characterize the ascites fluid and correlate clinical outcomes in those with extrahepatic malignancy and ascites.<bold>Methods: </bold>241 subjects with extrahepatic solid tumors and ascites were reviewed from 1/1/2000 to 12/31/2019, 119 without liver metastasis and 122 with liver metastasis.<bold>Results: </bold>Ascites fluid consistent with peritoneal carcinomatosis (PC) was most common, 150/241 (62%), followed by fluid reflecting the presence of portal hypertension (PH), 69/241 (29%). 22/241 (9%) had low SAAG and low ascites fluid total protein, with evidence of PC on cytology and or imaging in 20/22. Lung cancer was the most common malignancy in subjects with ascites due to PC at 36/150 (24%), pancreatic cancer was the most common in subjects with ascites with features of PH at 16/69 (23%). Chemotherapy or immunotherapy alone was the most common management approach. Significantly higher 5-year, 3-year and 1-year mortality rate were noted in subjects with evidence of PC on cytology/imaging versus subjects with no evidence of PC, and in subjects with liver metastasis compared to subjects without liver metastasis. Subjects with pancreatic cancer and evidence of PC on cytology/imaging had higher 1 and 5-year mortality rates compared to subjects without PC.<bold>Conclusions: </bold>Ascites in solid tumor malignancy is most commonly due to PC. We also observed ascites fluid with characteristics of PH in 29% of subjects. Higher mortality rates in subjects with peritoneal carcinomatosis and liver metastasis were noted. These findings may help inform prognosis and treatment strategies. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of BMC Gastroenterology is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=a9h&AN=158904581
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12876-022-02487-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 1
    Subjects:
      – SubjectFull: ASCITES
        Type: general
      – SubjectFull: LIVER metastasis
        Type: general
      – SubjectFull: TREATMENT effectiveness
        Type: general
      – SubjectFull: PORTAL hypertension
        Type: general
      – SubjectFull: PANCREATIC cancer
        Type: general
    Titles:
      – TitleFull: Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Alshuwaykh, Omar
      – PersonEntity:
          Name:
            NameFull: Cheung, Amanda
      – PersonEntity:
          Name:
            NameFull: Goel, Aparna
      – PersonEntity:
          Name:
            NameFull: Kwong, Allison
      – PersonEntity:
          Name:
            NameFull: Dhanasekaran, Renumathy
      – PersonEntity:
          Name:
            NameFull: Ghaziani, T. Tara
      – PersonEntity:
          Name:
            NameFull: Ahmed, Aijaz
      – PersonEntity:
          Name:
            NameFull: Daugherty, Tami
      – PersonEntity:
          Name:
            NameFull: Dronamraju, Deepti
      – PersonEntity:
          Name:
            NameFull: Kumari, Radhika
      – PersonEntity:
          Name:
            NameFull: Nguyen, Mindie
      – PersonEntity:
          Name:
            NameFull: Kim, W. Ray
      – PersonEntity:
          Name:
            NameFull: Kwo, Paul Yien
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 09
              Text: 9/5/2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 1471230X
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC Gastroenterology
              Type: main
ResultId 1